- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2013
- Public Summary Document (PSD) March 2013 PBAC Meeting - PDF
Mifepristone and misoprostol – March 2013
Mifepristone, tablet 200 mg, Mifepristone LinepharmaTM, and Misoprostol, tablet 200 microgram, GyMiso®
Last updated
8 November 2023
